Scarica l'app Stockscreener
27.96
0.21%
-0.06
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché PFE Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Pfizer Inc Borsa (PFE) Ultime notizie
Pfizer Advances PF-07248144 With Key Drug-Interaction Study Completion - TipRanks
Pfizer: Patient Investors Will Be Rewarded (NYSE:PFE) - Seeking Alpha
Pharma Stocks Have Rallied. 2 Stocks to Avoid—and 2 to Buy. - Barron's
Mitsubishi UFJ Trust & Banking Corp Grows Position in Pfizer Inc. $PFE - MarketBeat
Pfizer Inc. $PFE Shares Acquired by Russell Investments Group Ltd. - MarketBeat
Pfizer stock holds gains after Q2 2026 earnings beat and guidance raise - Ad-hoc-news.de
Global Retirement Partners LLC Makes New $4.34 Million Investment in Pfizer Inc. $PFE - MarketBeat
Bank of New York Mellon Corp Has $1.39 Billion Position in Pfizer Inc. $PFE - MarketBeat
What Is New for Pfizer (NYSE:PFE) Across Its Oncology Pipeline? - Kalkine Media
Pfizer (PFE) Rides MRNA Cancer Optimism On A Valuation That Still Looks Modest - simplywall.st
PCF-Pfizer Visiting Professorship Program 2026 for Precision Medicine in Prostate Cancer Care - Oncodaily
Pfizer (NYSE:PFE) Shares Down 1.5%Should You Sell? - MarketBeat
Pfizer Stock's Next Chapter Might Be Hiding in Plain Sight - Trefis
Quant MF raises Pfizer stake with Rs 131 cr purchase; Pari Washington buys over 2% in Amrutanjan Health Care - TradingView
Pfizer Stock Is A Race Between New Drugs And Old Patents - Trefis
Pfizer’s Ibrance Real-World Breast Cancer Study Wraps Up: What Investors Should Watch Next - TipRanks
Dividend Giants Pfizer, Chevron, AbbVie: Bold 2027 Price Targets Ahead - 24/7 Wall St.
Pfizer stock hits a fresh 52-week high as Q2 2026 earnings beat and guidance lift support the rally. - Ad-hoc-news.de
KBC Group NV Sells 144,649 Shares of Pfizer Inc. $PFE - MarketBeat
Janney Montgomery Scott LLC Has $58.14 Million Stock Position in Pfizer Inc. $PFE - MarketBeat
Why Is Pfizer (NYSE:PFE) Settling Thousands of Legal Claims? - Kalkine Media
Healthcare Stocks After Hours: Moderna, Merck Cool Following Cancer Trial GainsPfizer (NYSE:PFE), Mode - Benzinga
Pfizer (PFE) Breaks to a 52-Week High at $28.24, Clearing the April Peak - 24/7 Wall St.
Pfizer (PFE) Reaches Deal Covering About 5,000 Federal Lawsuit Claims - simplywall.st
Why Pfizer (PFE) Stock Is Trading Up Today - Yahoo Finance
Pfizer (NYSE:PFE) Shares Up 3.7%Still a Buy? - MarketBeat
A Look at Pfizer Inc (PFE) After 3.6% Gain -- GF Value $26.53 vs Price $28.24 - GuruFocus
PFE Stock Quote Price and Forecast - CNN
Which Drugmaker Stock Has Dominated in 2026: Merck, Pfizer, or Amgen? - 24/7 Wall St.
Pfizer Inc Stock (PFE) Moved Up by 3.96% on Aug 19: What Signal Does It Send? - TradingKey
Merck Just Raised the Stakes for Pfizer's Cancer Vaccine Ambitions - Benzinga
Pfizer Stock Rises Wednesday: What's Going On? - Benzinga
Pfizer's Obesity Push: Can Berobenatide Take Market Share? - Yahoo Finance
Pfizer Inc (PFE): A Closer Look Behind a 68 GF Score - GuruFocus
Insider Watch: 3 CEOs Betting Millions on Their Own Stocks - TradingView
Protalix (PLX) Q2 2026 Earnings Call Transcript - The Motley Fool
Pfizer Shares Gain 1.4% as Insider Acquisition Worth $3 Million Counters Reports of Fund Sales - TechStock²
Pfizer stock holds steady as investors weigh Q2 earnings beat and pipeline updates - Ad-hoc-news.de
Pfizer Inc. $PFE Shares Sold by Heritage Investors Management Corp - MarketBeat
TD Asset Management Inc Has $94.56 Million Stake in Pfizer Inc. $PFE - MarketBeat
Leuthold Group LLC Makes New Investment in Pfizer Inc. $PFE - MarketBeat
111 Capital Takes $3.71 Million Position in Pfizer Inc. $PFE - MarketBeat
Pfizer (NYSE:PFE) Trading Up 1.6%Here's Why - MarketBeat
Pfizer (PFE) Gets EMA Lyme Vaccine Filing Validation As ADC Patent Clout Grows - Yahoo Finance
Pfizer Pick of the Week at Smart Insider Following CEO's First Share Purchase - marketscreener.com
Pfizer: Still Cheap Valuation Meets A Looming Patent Cliff - Seeking Alpha
Pfizer Inc. $PFE Holdings Increased by Willis Investment Counsel - MarketBeat
University of Texas Texas AM Investment Management Co. Invests $3.97 Million in Pfizer Inc. $PFE - MarketBeat
Cornerstone Capital Inc. Grows Position in Pfizer Inc. $PFE - MarketBeat
Can Pfizer (NYSE:PFE) Pipeline Wins Offset Non-Cash Impairment Charges? - Kalkine Media
Albert Bourla Bought 9.6% More Shares In Pfizer - simplywall.st
Pfizer Advances Early Obesity Drug PF-08653944 With Phase 1 Study Completion - TipRanks
Pfizer stock steadies as investors focus on dividend and pipeline updates - AD HOC NEWS
Massachusetts Financial Services Co. MA Sells 360,819 Shares of Pfizer Inc. $PFE - MarketBeat
Vontobel Holding Ltd. Increases Stock Holdings in Pfizer Inc. $PFE - MarketBeat
Pfizer Inc. $PFE Shares Bought by Farther Finance Advisors LLC - MarketBeat
Diversified Trust Co. Has $3.64 Million Stock Holdings in Pfizer Inc. $PFE - MarketBeat
Advocate Group LLC Purchases 39,109 Shares of Pfizer Inc. $PFE - MarketBeat
Brian Sullivan: The $20 Million Bet That Resurrected Pfizer's Shelved Cancer Drug - finance.biggo.com
PFE price outlook: Pfizer pressing against 0.618 arc. Potential breakout toward $27.95 - FXStreet
Pfizer Stock And 2 AI Healthcare Picks Built Around Productivity Growth - simplywall.st
Patriot Financial Group Insurance Agency LLC Sells 90,653 Shares of Pfizer Inc. $PFE - MarketBeat
Hennessy Advisors Inc. Acquires 63,013 Shares of Pfizer Inc. $PFE - MarketBeat
Pfizer (PFE) Stock Looks Fully Valued At Today’s Price - webull.com
Pfizer Inc. - Encyclopedia Britannica
Pfizer’s CEO Just Bought $1 Million of Stock at $26. Here’s Where the Stock Could Go - TIKR.com
Pfizer Inc. $PFE Stock Position Lifted by Park National Corp OH - MarketBeat
Pfizer Inc. $PFE Holdings Lifted by QSM Asset Management Ltd - MarketBeat
Independent Financial Group LLC Purchases 57,994 Shares of Pfizer Inc. $PFE - MarketBeat
Pfizer Inc. • Robinhood Token Price, PFE Price, Live Charts, and Marketcap - Coinbase
Pfizer Inc. • Robinhood Token (PFE) Price, MarketCap, Charts and Fundamentals Info - BeInCrypto
Dividend HistoryPfizer (PFE) - Zacks Investment Research
New owner secures mystery tenant for Everett plant shelved by Pfizer - The Business Journals
Carol Devine Miller sells stocks in Pfizer, Quest Diagnostics, Target, and U.S. Bancorp - Investing.com
2.14%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):